Cargando…
Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790804/ https://www.ncbi.nlm.nih.gov/pubmed/36579352 http://dx.doi.org/10.2147/CMAR.S402092 |
_version_ | 1784859262622629888 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9790804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-97908042022-12-27 Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction] Cancer Manag Res Retraction Dove 2022-12-21 /pmc/articles/PMC9790804/ /pubmed/36579352 http://dx.doi.org/10.2147/CMAR.S402092 Text en © 2022 Dove Medical Press. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Retraction Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction] |
title | Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction] |
title_full | Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction] |
title_fullStr | Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction] |
title_full_unstemmed | Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction] |
title_short | Non-Coding RNA NEAT1/miR-214-3p Contribute to Doxorubicin Resistance of Urothelial Bladder Cancer Preliminary Through the Wnt/β-Catenin pathway [Retraction] |
title_sort | non-coding rna neat1/mir-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the wnt/β-catenin pathway [retraction] |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790804/ https://www.ncbi.nlm.nih.gov/pubmed/36579352 http://dx.doi.org/10.2147/CMAR.S402092 |